Verapamil Hydrochloride
- Product NDC
- 63629-7233
- 11-digit product format
- 636297233
- Labeler code
- 63629
- Product ID
- 63629-7233_90442f1f-bb05-4615-9ef1-73382c33e58a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Verapamil Hydrochloride
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- NDA020943
- Marketing category
- NDA
- Marketing start
- 1998-11-25
- Marketing end
- 0000-00-00
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 63629-7233 | D | Discontinued by firm | 2026-08-03 | ||
| excluded package | package | 63629-7233 | 63629-7233-1 | D | Discontinued by firm | 2026-08-03 | |
| excluded package | package | 63629-7233 | 63629-7233-2 | D | Discontinued by firm | 2026-08-03 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63629-7233-2 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63629-7233-1 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63629-7233-2 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63629-7233-1 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63629-7233-2 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63629-7233-1 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63629-7233-2 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63629-7233-1 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63629-7233-2 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63629-7233-1 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 63629-7233-2 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 63629-7233-1 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 63629-7233-2 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 63629-7233-1 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 63629-7233-2 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 63629-7233-1 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 63629-7233-2 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 63629-7233-1 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 63629-7233-2 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 63629-7233-1 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 63629-7233-2 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 63629-7233-1 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 63629-7233-2 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 63629-7233-1 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020943-001 | VERELAN PM | VERAPAMIL HYDROCHLORIDE | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | |
| N020943-002 | VERELAN PM | VERAPAMIL HYDROCHLORIDE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | |
| N020943-003 | VERELAN PM | VERAPAMIL HYDROCHLORIDE | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020943-002 | VERELAN PM | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020943-003 | VERELAN PM | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 1998-11-25 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N020943-001 | VERELAN PM | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1998-11-25 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N020943-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N020943-002 | AB | 1 | 74a2ff9319b5… |
| 2019-09-15 20:21 UTC | 2019-09 | N020943-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N020943-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N020943-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N020943-002 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE | Chartwell RX, LLC | 18f6d349-8c5c-4443-ac65-16bf6619ecdc | 2025-03-25 | Warnings, Adverse reactions | 020943 NDA020943 |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE | Wilshire Pharmaceuticals, Inc. | 5f665d08-e1e4-422a-88c2-d8834abf9e1a | 2024-11-27 | Warnings, Adverse reactions | 020943 NDA020943 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 63629-7233-1 | 63629723301 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63629-7233-1) | 2021-12-22 | 0000-00-00 | No | No | Current |
| 63629-7233-2 | 63629723302 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63629-7233-2) | 2017-03-23 | 0000-00-00 | No | No | Current |